Enhancer ID: | E_01_0579 |
Species: | human |
Position : | chr14:37586766-37588766 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Prostate cancer |
Pubmed ID: | 32333502 |
Enhancer experiment: | RNA isolation?RNA-seq? ChIP seq?ChIP-seq? |
Enhancer experiment description: | Enhancer activation was blocked at the chromatin level as evaluated by H3K27 acetylation (H3K27ac), H3K4 monomethylation (H3K4me1), and FOXA1, MED1 and BRD4 binding. |
Target gene : | -- |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Enhancer activation was blocked at the chromatin level as evaluated by H3K27 acetylation (H3K27ac), H3K4 monomethylation (H3K4me1), and FOXA1, MED1 and BRD4 binding. |
TF name : | FOXA1(HNF3A,TCF3A) |
TF experiment: | RNA isolation?RNA-seq? ChIP seq?ChIP-seq? |
TF experiment description: | Enhancer activation was blocked at the chromatin level as evaluated by H3K27 acetylation (H3K27ac), H3K4 monomethylation (H3K4me1), and FOXA1, MED1 and BRD4 binding. |
Enhancer function : | Enhancer activation was blocked at the chromatin level as evaluated by H3K27 acetylation (H3K27ac), H3K4 monomethylation (H3K4me1), and FOXA1, MED1 and BRD4 binding. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Enhancer activation was blocked at the chromatin level as evaluated by H3K27 acetylation (H3K27ac), H3K4 monomethylation (H3K4me1), and FOXA1, MED1 and BRD4 binding. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|---|---|---|
FOXA1 | AndrogenReceptor | netpath | 167 |
FOXA1 | Direct p53 effectors | pid | 141 |
FOXA1 | FOXA1 transcription factor network | pid | 45 |
FOXA1 | FOXA2 and FOXA3 transcription factor networks | pid | 45 |
FOXA1 | Hs_Endoderm_Differentiation_WP2853_88152 | wikipathways | 62 |